Key findings In an eight-week randomized, double-blind, placebo-controlled trial involving 50 adults seeking treatment for moderate-to-severe AUD, participants receiving oral semaglutide showed: Fewer heavy drinking days Reduced alcohol consumption per drinking occasion Lower day-to-day alcohol cravings Fewer alcohol-related problems Improved overall drinking risk level Reduced cannabis use days While not all measures changed in controlled laboratory settings, the overall pattern showed consistent reductions in harmful real-world drinking behavior

Lifestyle Considerations for Nutrient Optimisation Balanced Nutrition Still Matters While injections suppress appetite, try to eat nutrient-dense meals that prioritise: Lean proteins (chicken, fish, tofu) Leafy greens and coloured veg Whole grains (quinoa, oats) Healthy fats (nuts, seeds, olive oil) Hydration Is Non-Negotiable Aim for at least 2 litres of water daily to support detoxification, digestion, and reduce the risk of constipation and slowed gut motility
Research conducted by Cruz et al
The formula is lightweight and absorbs quickly, so it doesnt feel heavy or sticky
Review of the key results from the Swedish Obese Subjects (SOS) triala prospective controlled intervention study of bariatric surgery
The engineered hiPSC-MSCs successfully delivered GPx3 to the liver and ameliorated hepatic injury by inhibiting hepatic senescence [117]